Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000757406 | SCV000235918 | likely benign | not provided | 2020-03-11 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28831623, 27662471, 27016271) |
ARUP Laboratories, |
RCV000757406 | SCV000885614 | uncertain significance | not provided | 2017-10-22 | criteria provided, single submitter | clinical testing | The p.Leu53Met variant (rs200336608) was reported in one family investigated for dilated cardiomyopathy (DCM); however this variant did not segregate with affected individuals (Begay, 2016). This variant is listed in the Genome Aggregation Database (gnomAD) with a population frequency of 0.3 percent in the European Finnish population (identified on 82 out of 25,792 chromosomes), and has been reported to the ClinVar database as a variant of uncertain significance (Variation ID: 180371). The leucine at position 53 is highly conserved considering 13 species (Alamut v2.10) and computational analyses of the p.Leu53Met variant on protein structure and function indicate a deleterious effect (SIFT: damaging, MutationTaster: disease causing, PolyPhen-2: probably damaging). Altogether, there is not enough evidence to classify the p.Leu53Met variant with certainty. |
Labcorp Genetics |
RCV000157246 | SCV001002812 | benign | Primary familial hypertrophic cardiomyopathy | 2023-10-28 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000157246 | SCV000206976 | uncertain significance | Primary familial hypertrophic cardiomyopathy | 2013-12-20 | no assertion criteria provided | clinical testing |